The Procter & Gamble Company (NYSE:PG) Position Increased by Stanley Laman Group Ltd.

Stanley Laman Group Ltd. increased its position in shares of The Procter & Gamble Company (NYSE:PGFree Report) by 84.7% in the 1st quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 3,930 shares of the company’s stock after acquiring an additional 1,802 shares during the period. Stanley Laman Group Ltd.’s holdings in Procter & Gamble were worth $584,000 as of its most recent filing with the Securities and Exchange Commission.

Other hedge funds have also recently bought and sold shares of the company. EWG Elevate Inc. acquired a new position in Procter & Gamble during the fourth quarter worth $26,000. Silicon Valley Capital Partners acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at about $28,000. Legend Financial Advisors Inc. acquired a new stake in shares of Procter & Gamble in the third quarter valued at about $30,000. Luken Investment Analytics LLC acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at about $37,000. Finally, Kepos Capital LP acquired a new stake in shares of Procter & Gamble in the fourth quarter valued at about $38,000. 64.65% of the stock is owned by institutional investors and hedge funds.

Procter & Gamble Stock Performance

NYSE:PG opened at $149.38 on Friday. The Procter & Gamble Company has a 1 year low of $122.18 and a 1 year high of $158.11. The firm has a 50 day moving average of $150.50 and a 200-day moving average of $147.40. The company has a current ratio of 0.59, a quick ratio of 0.39 and a debt-to-equity ratio of 0.51. The stock has a market capitalization of $352.08 billion, a P/E ratio of 26.02, a price-to-earnings-growth ratio of 4.17 and a beta of 0.41.

Procter & Gamble (NYSE:PGFree Report) last posted its earnings results on Friday, April 21st. The company reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.32 by $0.05. Procter & Gamble had a net margin of 17.69% and a return on equity of 32.18%. The company had revenue of $20.07 billion during the quarter, compared to analysts’ expectations of $19.32 billion. During the same quarter in the previous year, the company posted $1.33 earnings per share. Procter & Gamble’s quarterly revenue was up 3.5% compared to the same quarter last year. As a group, sell-side analysts anticipate that The Procter & Gamble Company will post 5.86 EPS for the current fiscal year.

Procter & Gamble Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, May 15th. Investors of record on Friday, April 21st were issued a $0.9407 dividend. The ex-dividend date was Thursday, April 20th. This represents a $3.76 dividend on an annualized basis and a dividend yield of 2.52%. This is a positive change from Procter & Gamble’s previous quarterly dividend of $0.91. Procter & Gamble’s dividend payout ratio (DPR) is currently 65.51%.

Insider Activity at Procter & Gamble

In related news, CFO Andre Schulten sold 25,244 shares of the firm’s stock in a transaction that occurred on Monday, April 24th. The shares were sold at an average price of $155.27, for a total value of $3,919,635.88. Following the completion of the sale, the chief financial officer now owns 27,118 shares of the company’s stock, valued at $4,210,611.86. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. In other Procter & Gamble news, COO Shailesh Jejurikar sold 31,000 shares of Procter & Gamble stock in a transaction on Monday, May 1st. The shares were sold at an average price of $156.03, for a total transaction of $4,836,930.00. Following the completion of the sale, the chief operating officer now owns 10,014 shares of the company’s stock, valued at approximately $1,562,484.42. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Also, CFO Andre Schulten sold 25,244 shares of Procter & Gamble stock in a transaction on Monday, April 24th. The stock was sold at an average price of $155.27, for a total transaction of $3,919,635.88. Following the sale, the chief financial officer now directly owns 27,118 shares of the company’s stock, valued at approximately $4,210,611.86. The disclosure for this sale can be found here. Insiders sold a total of 95,093 shares of company stock valued at $14,821,930 over the last quarter. Corporate insiders own 0.26% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the company. Evercore ISI raised their price target on Procter & Gamble from $160.00 to $170.00 and gave the company an “outperform” rating in a research report on Monday, April 24th. Raymond James increased their target price on shares of Procter & Gamble from $170.00 to $175.00 and gave the company an “outperform” rating in a research note on Sunday, April 23rd. JPMorgan Chase & Co. upgraded shares of Procter & Gamble from a “neutral” rating to an “overweight” rating and increased their target price for the company from $150.00 to $155.00 in a research note on Friday, March 3rd. Royal Bank of Canada increased their target price on shares of Procter & Gamble from $160.00 to $165.00 and gave the company a “sector perform” rating in a research note on Monday, April 24th. Finally, Barclays increased their target price on shares of Procter & Gamble from $160.00 to $167.00 in a research note on Wednesday, April 26th. Five research analysts have rated the stock with a hold rating and twelve have issued a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $161.50.

Procter & Gamble Profile

(Free Report)

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.

Read More

Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PGFree Report).

Institutional Ownership by Quarter for Procter & Gamble (NYSE:PG)

Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.